Management of advanced prostate cancer in the Asia-Pacific region: Summary of the Asia-Pacific Advanced Prostate Cancer Consensus Conference 2023

CONCLUSION: The use of next-generation imaging, genetic testing, and new treatment combinations is increasing the complexity and duration of prostate cancer management. Familiarity with new diagnostic and treatment options is growing in the APAC region. Insights highlight the continued importance of a multidisciplinary approach that includes nuclear medicine, genetic counseling, and quality-of-life expertise. The APAC APCCC meeting provides an important opportunity to share practice and identify APAC-specific issues and considerations in areas of low evidence where clinical experience is growing.PMID:38628049 | DOI:10.1111/ajco.14064

Source: Clinical Prostate Cancer - April 17, 2024 Category: Cancer & Oncology Authors: Edmund Chiong Declan G Murphy Nicholas Buchan Kenneth Chen Sarah S Chen Melvin L K Chua Agus Rizal Hamid Ravindran Kanesvaran Makarand Khochikar Jason Letran Bannakij Lojanapiwat Indranil Mallik Chee Fai Ng Teng Aik Ong Darren M C Poon Yeong-Shiau Pu Marn Source Type: research